These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 315414
1. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol. Byers VS, Epstein WL, Castagnoli N, Baer H. J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414 [Abstract] [Full Text] [Related]
2. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response. Byers VS, Castagnoli N, Epstein WL. J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415 [Abstract] [Full Text] [Related]
3. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. Kalish RS, Johnson KL. J Immunol; 1990 Dec 01; 145(11):3706-13. PubMed ID: 2147199 [Abstract] [Full Text] [Related]
5. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. Kalish RS, Wood JA, LaPorte A. J Clin Invest; 1994 May 01; 93(5):2039-47. PubMed ID: 7910172 [Abstract] [Full Text] [Related]
8. A murine model system for contact sensitization to poison oak or ivy urushiol components. Dunn IS, Liberato DJ, Dennick RG, Castagnoli N, Byers VS. Cell Immunol; 1982 Apr 01; 68(2):377-88. PubMed ID: 6178516 [No Abstract] [Full Text] [Related]
9. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs. Watson ES, Murphy JC, Wirth PW, Waller CW, Elsohly MA. J Invest Dermatol; 1981 Mar 01; 76(3):164-70. PubMed ID: 6453903 [Abstract] [Full Text] [Related]
10. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates. Dupuis G. Br J Dermatol; 1979 Dec 01; 101(6):617-24. PubMed ID: 161173 [Abstract] [Full Text] [Related]
11. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen. Vidmar DA, Iwane MK. Am J Contact Dermat; 1999 Dec 01; 10(4):190-7. PubMed ID: 10594293 [Abstract] [Full Text] [Related]
12. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells. Kalish RS, Morimoto C. J Invest Dermatol; 1989 Jan 01; 92(1):46-52. PubMed ID: 2521239 [Abstract] [Full Text] [Related]
13. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood. Kalish RS, Morimoto C. J Clin Invest; 1988 Sep 01; 82(3):825-32. PubMed ID: 2458387 [Abstract] [Full Text] [Related]
14. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed. Long D, Ballentine NH, Marks JG. Am J Contact Dermat; 1997 Sep 01; 8(3):150-3. PubMed ID: 9249283 [Abstract] [Full Text] [Related]
19. Induction of suppressor T cells for lymph node cell proliferation after contact sensitization of mice with a poison oak urushiol component. Dunn IS, Liberato DJ, Castagnoli N, Byers VS. Immunology; 1984 Apr 01; 51(4):773-81. PubMed ID: 6231243 [Abstract] [Full Text] [Related]
20. GLC analysis of poison ivy and poison oak urushiol components in vegetable oil preparations. Elsohly MA, Turner CE. J Pharm Sci; 1980 May 01; 69(5):587-9. PubMed ID: 7381750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]